JOHANNESBURG (Reuters) – African countries that have not reported the circulation of the 501Y.V2 coronavirus variant first identified in South Africa should proceed with the rollout of the AstraZeneca COVID-19 vaccine, the African Union’s disease control body said on Thursday.
For countries that have reported circulation of the 501Y.V2 variant, they should accelerate their preparedness to introduce all vaccines that have received emergency use authorisation, Africa CDC Director John Nkengasong told a news conference.
“Consideration should be given to the effectiveness of the vaccine against the 501Y.V2variant,” Nkengasong said.
(Reporting by Alexander Winning and Olivia Kumwenda-Mtambo; Editing by Alison Williams)
